Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laryngeal chondrosarcomas

C A Moran1, S Suster, D Carter

  • 1Department of Surgical Pathology, Yale-New Haven, Conn.

Archives of Pathology & Laboratory Medicine
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reframing loss of efficacy in sacral neuromodulation: a neurofunctional service model for coloproctology.

Techniques in coloproctology·2026
Same author

Assessment of Esophageal Emptying in Patients with Dysphagia: Differences Between High-Resolution Impedance Manometry and Timed Barium Esophagram.

Acta gastro-enterologica Belgica·2025
Same author

Efficacy and safety of RD2 Ver.02, a whole blood clot therapy, coupled with a minimally invasive procedure in pilonidal sinus: a phase II study.

Techniques in coloproctology·2024
Same author

Convolutional neural network deep learning model accurately detects rectal cancer in endoanal ultrasounds.

Techniques in coloproctology·2024
Same author

Surgical outcomes of minimally invasive trephine surgery for pilonidal sinus disease with and without laser therapy: a comparative study.

Techniques in coloproctology·2023
Same author

Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK.

The International journal on drug policy·2023
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Laryngeal chondrosarcomas are rare tumors. Histologic grade, size, and location are crucial for prognosis, with low-grade tumors showing better outcomes after surgery.

Area of Science:

  • Otolaryngology
  • Pathology
  • Oncology

Background:

  • Chondrosarcoma of the larynx is a rare malignant tumor.
  • This study presents four cases to analyze clinical and pathological features.

Observation:

  • Cases involved patients aged 60-75 years (1 male, 3 female).
  • Tumor locations included thyroid, cricoid, and arytenoid cartilages.
  • One myxoid chondrosarcoma of the arytenoid showed rapid metastasis and a fatal outcome.

Findings:

  • Three cases of low-grade, well-differentiated hyaline chondrosarcoma had favorable outcomes.
  • Patients were disease-free 3-6 years post-laryngectomy (total or partial).

Implications:

  • Histologic grade, tumor size, and location are critical prognostic factors.

Related Experiment Videos

  • Surgical management (total or partial laryngectomy) can be effective for low-grade laryngeal chondrosarcomas.
  • Further research into rare laryngeal neoplasms is warranted.